Taken together, the results from flow cytometry demonstrate that both protocols were able to generate the populations of interest, including CS MBCs and CS PBs, and showed that condition II stimulation protocol is more effective than condition I in enhancing in vitro expansion of CD19+ B-cells in HCs and CVID patients. The gene discussed is CD19; the disease is common variable immunodeficiency.